COVID-19

Remdesivir has emerged as one of the most promising drug candidates for the treatment of COVID-19. But, is it affordable for…

Since the onset of the COVID-19 pandemic earlier this year, the FDA has issued a series of temporary emergency approvals ranging…

Izana Bioscience's Namilumab, a monoclonal antibody already in late-stage tests to treat rheumatoid arthritis and an inflammatory…

Collaboration will enable global development, manufacturing and distribution of the Candidate COVID-19 vaccine

Kaka-Ba hospital, a CSR initiative of Cadila Pharmaceuticals located in Hansot, has been working towards building awareness in the…

COVID-19 and drug resistance are threatening to derail the progress made against the HIV, malaria and TB epidemics, and this may…

The assessment of the benefits and risks of remdesivir is being performed under a reduced timeline and an opinion could be issued…

IPA in collaboration with Accenture has conducted a study that details out the best ways to revive the Pharma Ancillary Industry…

Industry experts express the need for amendments and clarity in existing regulations for AYUSH products in the larger public…

Reportedly, AstraZeneca contacted Gilead last month but the latter is not interested in merging or selling to another big pharma…